Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1998
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2285580A1 Gastroretentive controlled release microspheres for improved drug delivery
11/25/1998EP0879245A1 Synthetic il-10 analogues
11/25/1998EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998EP0879059A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon
11/25/1998EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998EP0700283B1 Liquid antacid compositions
11/25/1998EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1199634A Medicine for hernia and its preparation process and medicated deltoid belt
11/25/1998CN1199627A Hepatitis curing medicine
11/25/1998CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840910 Pyridine derivatives having anti-ulcerative activity
11/24/1998US5840903 5-ht3 and 5-ht4 agonists and antagonists
11/24/1998US5840860 Delivering fatty acid to colon by linking fatty acid to a carbohydrate carrier
11/24/1998US5840747 Calcium channel antagonists
11/24/1998US5840725 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/24/1998US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998US5840682 Peptide antagonists of neurotensin
11/24/1998US5840552 Using microorganisms or microbial enzyme system to produce stereospecific enantiomers; antiulcer agents
11/24/1998US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs
11/24/1998US5840498 Antibiotic cryptdin peptides and methods of their use
11/24/1998US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate
11/24/1998US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051686A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051655A1 Excitatory amino acid receptor modulators
11/19/1998WO1998051348A2 Sustained-release delayed gels
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2289573A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998EP0878463A1 Excitatory amino acid receptor modulators
11/18/1998EP0878199A1 Natural teas for taking off the effects of drink and process for the production thereof
11/18/1998EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998EP0877716A1 Bioactive glass compositions and methods of treatment using bioactive glass
11/18/1998EP0877623A1 Intranasal vaccination against gastrointestinal disease
11/18/1998CN1199399A Naphthamide derivs, of 3-beta-amino azabicyclo octane or nonane as neuroleptic agents
11/18/1998CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998CN1198948A Medicine for gastroenteritic diseases and its preparation process
11/17/1998US5837702 4-arylamino-benzopyran and related compounds
11/17/1998US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998US5837472 Nucleotide sequences coding for a protein with urease activity
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/13/1998CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050534A1 Protease inhibitors
11/12/1998WO1998050533A1 Protease inhibitors
11/12/1998WO1998050383A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998WO1998050381A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998WO1998050342A1 Protease inhibitors
11/12/1998WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998WO1998050019A1 Stable oral pharmaceutical dosage forms
11/12/1998WO1998032428A3 Compositions comprising choline and use of choline to treat endotoxic shock
11/12/1998CA2289602A1 Protease inhibitors
11/12/1998CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998CA2289010A1 Protease inhibitors
11/12/1998CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998CA2288868A1 Protease inhibitors
11/12/1998CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
11/11/1998EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0876158A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/11/1998EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
11/11/1998CN1198778A Aspergillus arabinofuranosidase
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198746A Tricyclic benzazepine vasopressin antagonists
11/11/1998CN1198743A Pyrimidine derivatives as 5HT2c-receptor antagonists
11/11/1998CN1198350A Fushuixiao oral liquor (medicine for eliminating ascites) and preparing process
11/11/1998CN1198345A Powder medicine for diarrhea
11/11/1998CN1198343A Medicinal composition for urcerative celitis
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/11/1998CN1040645C Compound with 5-HT4 receptor rivalry activity, its preparation and pharmaceutical composition containing said compound
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834494 Pyridylcarbamoyl Indolines